Protein Based Vaccines

Protein based subunit antibodies exhibit an antigen to the safe framework without viral particles, utilizing a particular, confined protein of the pathogen.

Acellular pertussis (AP) antibodies contain inactivated pertussis poison (protein) and may contain at least one other bacterial parts.

Hepatitis B immunizations are made out of the hepatitis B infection surface antigen (HbsAg), a protein created by hepatitis B infection. Prior immunization items were created utilizing purged plasma of tainted people. This creation technique has been supplanted by recombinant innovation that can deliver HbsAg without requiring human plasma expanding the security of the immunization by barring the hazard from potential tainting of human plasma.

  • Contraindications - Vaccines, vaccination
  • New approaches to combat bacterial pathogens
  • Public health concerns in vaccination
  • Vaccine resistance and need of Next-Gen Conjugate Vaccines
  • Vaccines formulation and technologies used in conjugated vaccines

Related Conference of Protein Based Vaccines

December 06-07, 2018

International Congress on Vaccines & Immunology

Amsterdam, Netherlands
March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

New York, USA
March 18-19, 2019

35th World Vaccines & Immunization Congress

Novotel Brisbane, Australia
March 21-22, 2019

32nd International Conference on Vaccines and Immunization

Hotel Holiday Inn, Aurelia Rome, Italy
August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland, New Zealand

Protein Based Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in